|4Feb 22, 12:41 PM ET

Sagent Pharmaceuticals, Inc. 4

4 · Sagent Pharmaceuticals, Inc. · Filed Feb 22, 2016

Insider Transaction Report

Form 4
Period: 2016-02-18
Drake Lorin
VP, Sales and Marketing
Transactions
  • Tax Payment

    Common Stock

    2016-02-18$15.16/sh452$6,85232,077 total

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT